Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: January 2015

Michele Brown to Leave EDA to Head Choose NJ; Founding CEO Returning to Texas

Trenton, NJ, January 23, 2015 NJBIZ reports that Michele Brown will step down as CEO of the state Economic Development Authority to become the CEO and president of Choose New Jersey, the privately funded business attraction arm of the state.

Choose New Jersey’s board approved the hiring of Brown during a meeting Thursday afternoon. She will fill the post left vacant by Choose New Jersey’s founding CEO, Tracye McDaniel, who announced last month that she was leaving to lead the Texas Economic Development Corp. Continue reading

Rutgers University Surpasses $1 Billion Fundraising Goal

New Brunswick, NJ, January 22, 2015 ― Rutgers University has successfully completed the largest and most comprehensive fundraising campaign in the university’s nearly 250-year history, surpassing the campaign’s $1 billion goal by almost 4 percent, Rutgers President Robert Barchi announced today.

The seven-and-a-half-year “Our Rutgers, Our Future” campaign — which formally ended on Dec. 31, 2014 — raised a total of $1,037,056,700, President Barchi said.

“The success of our fundraising campaign is a testament to the incredible vision of our more than 130,000 donors, including more than 70,000 alumni, whose generosity supports programs and initiatives in every area of our university,” President Barchi said. Continue reading

President Calls for Major Increase in Medical Research into Antibiotic Resistance, ‘Precision Medicine’

Washington, DC, January 21, 2015 The Wall Street Journal today reported that President Barack Obama called for a new medical research push in his State of the Union address, which the White House says will include fighting antibiotic resistance and the pursuit of targeted therapy based on a patient’s genetic makeup.

The beefed-up research into antibiotic resistance, while not further specified in the President’s address to the nation on Tuesday night, would potentially include new medicines that could be reviewed by the Food and Drug Administration, and new ways to avoid antibiotics’ becoming less effective.  The White House said the plan is to nearly double the federal investment into grappling with the issue of antibiotic resistance. Continue reading

January Is National Blood Donor Month: An Opportunity to Make a Lifesaving Difference

Trenton, NJ, January 21, 2015 ― January is National Blood Donor Month.  It aims to provide people an opportunity to roll up their sleeves and donate blood or pledge to give blood at a time of the year when this lifesaving commodity is typically in short supply.

Nine out of 10 people will need blood at some time in their lives due to illness, to treat an injury or during surgery.  There is no artificial substitute for blood.  A unit of blood from a single donor can save up to three lives.

“People can make a real difference in other people’s lives by donating blood,” said Health Commissioner Mary O’Dowd.  “National Blood Donor Month is the perfect time to thank New Jersey donors for giving the gift of life through blood, platelet and plasma donations, and to encourage first time donors to participate in blood drives through their workplace, school or community.” Continue reading

Rider University to Offer Bachelor’s Degree in Health Care Management

Lawrenceville, NJ, January 20, 2015 Rider University has announced a new bachelor of science in business administration in health care management, offered by the university’s College of Business Administration.  The degree provides a core education in business combined with critical topics in health care management.

Anne Carroll, interim dean of Rider’s College of Business Administration, said, “There is no field more exciting and relevant today than health care management.  Health care is driving our economy both in New Jersey and nationally, and a well-rounded degree intersecting business and health care is high in demand.” Continue reading

Rutgers Names Dr. Jasjit Ahluwalia as Dean of School of Public Health

New Brunswick, NJ, January 20, 2015 ― Jasjit S. Ahluwalia, M.D., a nationally recognized researcher in the fields of health disparities and nicotine addiction in minority populations, has been chosen as dean of the Rutgers School of Public Health, effective April, 2015.

Currently, Ahluwalia is a professor of internal medicine and epidemiology at the University of Minnesota Academic Health Center, where he was recruited in 2005 to become the founding executive director of the Office of Clinical Research.

Ahluwalia recently completed his term as chair of the National Advisory Council for Minority Health and Health Disparities at the National Institutes of Health. He was appointed to the council by former HHS Secretary Kathleen Sebelius. Continue reading

U.S. Senators Re-Introduce Bill to Speed Approval of Antibiotics

Lawrenceville, NJ, January 19, 2015 ― Pharmalot reports that, in the latest bid to combat antibiotic resistance, two U.S. senators have re-introduced legislation to create a so-called regulatory pathway to hasten approval of new treatments.

Known as the Promise for Antibiotics and Therapeutics for Health Act (PATH), the bill would accelerate approval for a serious or life-threatening condition that addresses an unmet medical need.  The PATH act would also require labeling to include a special FDA designation indicating intended use in limited, high-risk populations. Continue reading

Seton Hall and Hackensack University Health Network to Open Medical School on Roche Property

Nutley, NJ, January 15, 2015 NJBIZ reports that Hackensack University Health Network and Seton Hall University today formally announced their plans to start the state’s first four-year, private medical school on the campus of the former Roche headquarters in Nutley and Clifton.

Alongside Seton Hall President A. Gabriel Esteban, Hackensack CEO and President Robert C. Garrett called the plan a “game-changer” and an “absolutely monumental event.” Continue reading

Choose NJ Offers Five Web Tools to Help Grow Garden State Businesses

Princeton, NJ, January 14, 2015 ― Five powerful online tools offered by Choose New Jersey are helping New Jersey businesses, municipalities and economic development organizations thrive.

A privately funded and governed nonprofit organization, Choose New Jersey markets the state across the world in an effort to grow jobs and investment in the Garden State.

“With more than 90 percent of the research for site selection done online, before an economic development organization or municipality is ever contacted, it is increasingly important for states and communities to have a robust and diversified digital strategy that allows them to compete for business investment,” said Jenn Kramer, chief marketing officer of Choose New Jersey.

“The easy-to-use tools,” Kramer added, “are helping put information at the fingertips of those who need it and they’re helping us nurture economic growth throughout the state.” Continue reading

FDA to Create New Drug Quality Office to Focus on Manufacturing

Washington, DC, January 13, 2015 The Wall Street Journal has reported that the Food and Drug Administration plans to create a new Office of Pharmaceutical Quality to focus in part on manufacturing problems such as those that have beset generic companies that make extended-release versions of drugs.

The agency said it isn’t creating the office because of quality concerns, but rather to make its focus on manufacturing more systematic.

Dr. Janet Woodcock, director of the FDA’s center for drugs, said the office is intended in part to create parity between brand-name and generic drugs. Continue reading